Legacy Novozymes delivers solid last full-year results
01 févr. 2024 02h00 HE
|
Novozymes A/S
Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks...
Results update for 2023 – unaudited
01 févr. 2024 01h59 HE
|
Novozymes A/S
6% organic sales growth in Q4 and 5% for the full year with solid margins and free cash flow generation As Novozymes just closed the combination with Chr. Hansen on January 29, and the annual...
Total number of voting rights and capital on January 31, 2024
31 janv. 2024 08h20 HE
|
Novozymes A/S
Total number of voting rights and capital on January 31, 2024 January 31, 2024Company announcement No. 05 Referring to company announcement 02, on January 29, 2024, where Novozymes A/S...
Trading by management and close relations of management
29 janv. 2024 09h59 HE
|
Novozymes A/S
January 29, 2024Company announcement No. 04 Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on...
Major shareholder announcement
29 janv. 2024 07h13 HE
|
Novozymes A/S
Major shareholder announcement January 29, 2024Company announcement No. 03 On January 29, 2024, following the satisfaction of all conditions precedent, the combination of...
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
29 janv. 2024 05h27 HE
|
Novozymes A/S
Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for...
Completion of the combination between Novozymes and Chr. Hansen
29 janv. 2024 05h25 HE
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2024_02_Completion_Of_The_Combination
...
All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen
26 janv. 2024 06h06 HE
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2024_01_All_Regulatory_Approvals_Obtained
...
South Korean merger approval granted
20 déc. 2023 09h00 HE
|
Novozymes A/S
Please read the full announcement in the attached PDF
Attachment
2023_South Korean merger approval granted
...
Novozymes’ updated financial calendar
13 déc. 2023 08h46 HE
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2023_61_Updated_financial_calendar
...